212 related articles for article (PubMed ID: 33053805)
1. Chiral Cyclobutane-Containing Cell-Penetrating Peptides as Selective Vectors for Anti-
Illa O; Olivares JA; Gaztelumendi N; Martínez-Castro L; Ospina J; Abengozar MÁ; Sciortino G; Maréchal JD; Nogués C; Royo M; Rivas L; Ortuño RM
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053805
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Cyclobutane/Proline-Containing Peptidomimetics: The Conformational Constraint Influences Their Cell-Penetration Ability.
Illa O; Ospina J; Sánchez-Aparicio JE; Pulido X; Abengozar MÁ; Gaztelumendi N; Carbajo D; Nogués C; Rivas L; Maréchal JD; Royo M; Ortuño RM
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065025
[TBL] [Abstract][Full Text] [Related]
3. Searching for new cell-penetrating agents: hybrid cyclobutane-proline γ,γ-peptides.
Gorrea E; Carbajo D; Gutiérrez-Abad R; Illa O; Branchadell V; Royo M; Ortuño RM
Org Biomol Chem; 2012 May; 10(20):4050-7. PubMed ID: 22514076
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
Dragojevic S; Mackey R; Raucher D
Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
[TBL] [Abstract][Full Text] [Related]
6. Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.
Xiang Y; Shan W; Huang Y
Int J Pharm; 2018 Nov; 551(1-2):14-22. PubMed ID: 30205127
[TBL] [Abstract][Full Text] [Related]
7. New Cell-Penetrating Peptide (KRP) with Multiple Physicochemical Properties Endows Doxorubicin with Tumor Targeting and Improves Its Therapeutic Index.
Yu M; Li X; Huang X; Zhang J; Zhang Y; Wang H
ACS Appl Mater Interfaces; 2019 Jan; 11(2):2448-2458. PubMed ID: 30576099
[TBL] [Abstract][Full Text] [Related]
8. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structural study of highly constrained hybrid cyclobutane-proline γ,γ-peptides.
Gutiérrez-Abad R; Carbajo D; Nolis P; Acosta-Silva C; Cobos JA; Illa O; Royo M; Ortuño RM
Amino Acids; 2011 Aug; 41(3):673-86. PubMed ID: 21541681
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
Young Kim H; Young Yum S; Jang G; Ahn DR
Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
12. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H
Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120
[TBL] [Abstract][Full Text] [Related]
13. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
14. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
Lelle M; Frick SU; Steinbrink K; Peneva K
J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
[TBL] [Abstract][Full Text] [Related]
15. Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.
Park H; Tsutsumi H; Mihara H
Biomaterials; 2013 Jul; 34(20):4872-9. PubMed ID: 23545289
[TBL] [Abstract][Full Text] [Related]
16. Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery.
Kang MH; Yoo HJ; Kwon YH; Yoon HY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
Mol Pharm; 2015 Dec; 12(12):4200-13. PubMed ID: 26544061
[TBL] [Abstract][Full Text] [Related]
17. Ribbon-like Foldamers for Cellular Uptake and Drug Delivery.
Vezenkov LL; Martin V; Bettache N; Simon M; Messerschmitt A; Legrand B; Bantignies JL; Subra G; Maynadier M; Bellet V; Garcia M; Martinez J; Amblard M
Chembiochem; 2017 Nov; 18(21):2110-2114. PubMed ID: 28863239
[TBL] [Abstract][Full Text] [Related]
18. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
[TBL] [Abstract][Full Text] [Related]
19. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
Elife; 2021 Oct; 10():. PubMed ID: 34713805
[TBL] [Abstract][Full Text] [Related]
20. A BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48-60) peptide favors intracellular delivery and visualization of the antiparasitic drug.
de la Torre BG; Hornillos V; Luque-Ortega JR; Abengózar MA; Amat-Guerri F; Acuña AU; Rivas L; Andreu D
Amino Acids; 2014 Apr; 46(4):1047-58. PubMed ID: 24445871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
